Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 10, 2024. (Total: 234259Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Thrombocytopenia and CALR[original query]
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Blood 2014 Aug 124 (7): 1062-9.
Rumi Elisa, Pietra Daniela, Pascutto Cristiana, Guglielmelli Paola, Martínez-Trillos Alejandra, Casetti Ilaria, Colomer Dolors, Pieri Lisa, Pratcorona Marta, Rotunno Giada, Sant'Antonio Emanuela, Bellini Marta, Cavalloni Chiara, Mannarelli Carmela, Milanesi Chiara, Boveri Emanuela, Ferretti Virginia, Astori Cesare, Rosti Vittorio, Cervantes Francisco, Barosi Giovanni, Vannucchi Alessandro M, Cazzola Mario,
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
British journal of haematology 2015 Apr 169 (1): 71-6.
Wassie Emnet, Finke Christy, Gangat Naseema, Lasho Terra L, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis.
British journal of haematology 2016 Jun .
Beauverd Yan, Alimam Samah, McLornan Donal P, Radia Deepti H, Harrison Claire
Momelotinib therapy for myelofibrosis: a 7-year follow-up.
Blood cancer journal 2018 3 8 (3): 29.
Tefferi Ayalew, Barraco Daniela, Lasho Terra L, Shah Sahrish, Begna Kebede H, Al-Kali Aref, Hogan William J, Litzow Mark R, Hanson Curtis A, Ketterling Rhett P, Gangat Naseema, Pardanani Anime
[Ruxolitinib combined with prednisone, thalidomide and danazol for treatment of myelofibrosis: a pilot study].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2019 2 40 (1): 24-28.
Xu Z F, Qin T J, Zhang H L, Fang L W, Pan L J, Hu N B, Qu S Q, Li B, Xiao Z
WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis.
Blood cells, molecules & diseases 2019 1 75 35-40.
Cottin Laurane, Riou Jérémie, Boyer Françoise, Bouvier Anne, Zannetti Alain, Blouet Anaïse, Truchan-Graczyk Matgorzata, Jouanneau-Courville Rébecca, Beucher Annaëlle, Ribourtout Bénédicte, Orvain Corentin, Hunault-Berger Mathilde, Blanchet Odile, Ugo Valérie, Luque Paz Dami
[Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 8 41 (7): 576-582.
Tan Y X, Xu N, Huang J X, Wu W E, Liu L, Zhou L L, Liu X L, Yin C X, Xu D, Zhou
High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis.
Journal of applied genetics 2023 7 .
Zuzanna Kandu?a, Micha? Janowski, Barbara Wi?ckowska, Edyta Paczkowska, Aleksandra Mroczkowska-B?karciak, Marta Sobas, Krzysztof Lewandows
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (3): 100016.
Al-Ghamdi Yahya A, Lake Jonathan, Bagg Adam, Thakral Beenu, Wang Sa A, Bueso-Ramos Carlos, Masarova Lucia, Verstovsek Srdan, Rogers Heesun J, Hsi Eric D, Gralewski Jonathon H, Chabot-Richards Devon, George Tracy I, Rets Anton, Hasserjian Robert P, Weinberg Olga K, Parilla Megan, Arber Daniel A, Padilla Osvaldo, Orazi Attilio, Tam Way
TOP